Perhaps more than any other childhood cancer, pediatric brain tumor treatment is incredibly complex and takes a team effort to care for a patient. Doctors and researchers are working to not only improve medicines and treatment methods, they are also striving to improve quality of life and long-term side effects for young patients.
“The goal isn’t to have just one person treat a child, it’s about having several people all putting together their expertise to care for the patient,” says Mark Kieran, MD, PhD, clinical director of the Pediatric Brain Tumor Center at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Read more:
In this Cancer Conversations podcast episode, Kieran joins Peter Manley, MD, a pediatric neuro-oncologist and director of the Stop & Shop Family Pediatric Neuro-Oncology Outcomes Clinic, for a discussion on the latest in pediatric brain tumor treatment. Kieran and Manley discuss precision medicine, immunotherapy, and radiation therapy, as well as new information about the long-term survival of patients and ways to reduce treatment side effects.
Listen to the podcast episode below or click “download” to listen later. Subscribe options are also available via iTunes, Google Play, the Stitcher app, TuneIn app, and RSS.
The Cancer Conversations series features Q&A-style conversations with Dana-Farber physicians, clinicians, and researchers. Topics include breast cancer research, precision cancer medicine, integrative therapies, cancer genetics, and more. Visit the Cancer Conversations page for more episodes and the Dana-Farber podcast page for more cancer podcast series.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | RSS